Navigation Links
New Avian Flu Vaccine Strategy Proposed
Date:10/8/2008

Advance shots protect those most exposed in possible pandemic, researchers suggest

WEDNESDAY, Oct. 8 (HealthDay News) -- People can be protected against a potential avian flu epidemic by getting advance shots of a vaccine that may or may not be effective against the strain causing the epidemic, British researchers suggest.

That apparently daffy strategy is scientifically sound, according to a letter in the Oct. 9 issue of the New England Journal of Medicine, because priming people with an old vaccine would make any new vaccine work faster and better.

A study of 24 people who got a now outdated avian flu vaccine seven years ago shows the strategy would work, said Dr. Iain Stephenson, a senior lecturer in infectious disease at the University of Leicester.

Those people quickly developed flu-fighting antibodies when challenged with the H5 avian flu strain that is regarded as the one most likely to spread from birds to humans and cause an epidemic, Stephenson said.

In June, U.S. researchers reported that they had developed a bird flu vaccine that appeared to be safe and more effective than the one currently approved for human use.

Three-quarters of volunteers produced antibodies against the virus after receiving a second dose of the vaccine, CELVAPAN, made by Baxter, compared with only 45 percent in the currently approved vaccine. Baxter conducted the study.

"If there were to be a pandemic of avian influenza, a vaccine would be the principal means of protecting the public," Stephenson said. "Because most people would be naive to the strain, it would very likely take two doses to produce an immune response. It is very challenging to give two doses."

And while governments have stockpiled vaccines against the H5 strain, "there are two problems," Stephenson said. "Is that vaccine a good match to the pandemic strain? H5 changes, and the emerging strain could be distant to the stockpiled vaccine.

"And considering the speed with which the pandemic might spread, even if you've got a stockpiled vaccine, it would be a challenge to use that vaccine in a two-dose strategy. But if you've got people who have been primed in advance, as we took people who were primed seven years ago, it's possible to give a single low-dose vaccine and show they get a rapid response that is reactive to all known strains."

"It's a very intriguing idea," said Ted Ross, an assistant professor of microbiology at the University of Pittsburgh Center for Vaccine Research.

Ross agreed that the current strategy of giving two flu vaccine shots two weeks apart might not meet the urgent needs of a pandemic. "I believe it is going to take too long in a bird flu pandemic," he said. "Priming the population might be protective against a wide variety of H5 viruses that we know have infected humans already. The broader the protection, the better."

However, there would be financial barriers to a program that would prime a large part of the population along the lines of the Stephenson proposal, Ross noted. "Even with the currently tested vaccine, there currently is no market for vaccinating people widely," he said.

Not everyone need be primed, Stephenson said. "You would be preparing for an event that might never happen, so safety considerations would be paramount," he said. "It is unlikely that the entire population would be covered. It might be proposed to take key personnel, first responders to a pandemic. That is a potential approach that should be considered."

Even then, a single study of 24 people is not enough to prompt such a program, Stephenson noted. "It is important that larger studies be done to confirm the finding," he said.

More information

The status of avian flu vaccines is described by the Centers for Disease Control and Prevention.



SOURCES: Iain Stephenson, M.D., senior lecturer, infectious disease, University of Leicester, England; Ted Ross, Ph.D., assistant professor, microbiology, University of Pittsburgh Center for Vaccine Research; Oct. 9, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Influenza: Insights into cell specificity of human vs. avian viruses
2. Large avian flu outbreaks more likely to involve duck meat industry, experts find
3. iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning
4. Penn animal study identifies new DNA weapon against avian flu
5. Booster vaccination may help with possible future avian influenza pandemic
6. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
7. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
8. Vaccine Stops Alzheimers Brain Tangles
9. Human Papilloma Virus vaccines may decrease chances of oral cancer
10. U.S. Teens Fall Short on Vaccine Coverage
11. Nasal Anthrax Vaccine Proves Effective in Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Avian Flu Vaccine Strategy Proposed
(Date:12/8/2016)... ... 08, 2016 , ... Coppin Insurance Agency, an insurance and financial planning firm ... Cape Coral area, is embarking on a charity drive with the goal of providing ... Harry Chapin Food Bank of Southwest Florida works to provide fresh and nutritious food ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... drug in their bodies, a researcher at the Icahn School of Medicine at ... , The study found that when young children are exposed to secondhand marijuana ...
(Date:12/7/2016)... ... December 07, 2016 , ... EnghouseSystems ... purchase price of approximately $17.4 million (net of the cash acquired), subject ... $13.2 million. Headquartered in Barcelona, Spain, Presence is a leading provider of ...
(Date:12/7/2016)... ... 2016 , ... A quote from Dr. Edward Hallowell, host of CRN International’s ... offer a rare glimpse into the mind of those people with ADHD. , Dr. ... author, has described people with ADHD as having “Ferrari engines for a brain, with ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016  Northwest Biotherapeutics (Nasdaq: ... "Company"), a biotechnology company developing DCVax® personalized immune ... the Nasdaq Staff has not accepted the Company,s ... Rules previously reported, and the Company has notified ... Company,s common stock from listing on Nasdaq.  Upon ...
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... Kan. , Dec. 7, 2016   Rx Savings ... West Virginia and its Public Employees Insurance Agency ... members access to their innovative healthcare software, ultimately saving money ... with PEIA and provide its members with access to our ... or a more effective, affordable therapy can be found," says ...
Breaking Medicine Technology: